FASEB SRC on Biological Methylation: Regulation of Chromatin, Epigenetics, and Di

FASEB SRC 关于生物甲基化：染色质、表观遗传学和 Di 的调节

• 批准号: 8720359
• 负责人: Or P. Gozani
• 金额: $ 0.67万
• 依托单位: FEDERATION OF AMER SOC FOR EXPER BIOLOGY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-23 至 2015-04-22
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8720359
• 关键词: American; Area; Arginine; Bahamas; Biochemistry; Biological; Biological Process; Biology; Cell physiology; Chemicals; Chromatin; Collaborations; DNA; DNA Damage; DNA Methylation; DNA Methyltransferase; DNA Modification Methylases; Development; Disease; Educational workshop; Environment; Enzymatic Biochemistry; Epigenetic Process; Evolution; Funding; Gene Expression; Genome; Genome Stability; Goals; Histones; Human Development; Individual; Institution; Lysine; Malignant Neoplasms; Methionine; Methylation; Methyltransferase; Modification; Molecular; Participant; Pattern; Play; Postdoctoral Fellow; Protein Methyltransferases; Proteins; Reading; Regulation; Request for Proposals; Research; Research Personnel; Resort; Role; Running; S-Adenosylmethionine; Science; Scientist; Senior Scientist; Series; Signal Transduction; Societies; Structure; Technology; Therapeutic; Time; Transcriptional Regulation; abstracting; base; demethylation; design; epigenome; graduate student; human disease; interest; macromolecule; meetings; posters; programs; public health relevance; research and development; response; symposium

DESCRIPTION (provided by applicant): This proposal seeks partial support for the 2014 Federation of American Societies for Experimental Biology (FASEB) summer research conference on "Biological Methylation: Regulation of Chromatin, Epigenetics, and Disease". This will be the eleventh biennial conference on this topic and will be held from July 06-12, 2014 at the Sheraton Casino and Resort, Nassau, Bahamas. The "Biological Methylation" conference has historically taken a unique approach in its integrative coverage of the enzymology, function, and recognition of S-adenosylmethionine-dependent methylation and its influence on diverse biological processes and disease. Over the last twenty years, this meeting has evolved a particular focus on topics relating to DNA and histone methylation, and the role of these epigenetic modifications in development and disease. Recent advances in the areas of epigenetic reprogramming, which involves the resetting of DNA and histone methylation patterns during development and disease, and the evolution of genome-scale technologies to comprehensively evaluate DNA methylation and histone methylation have put this field at the forefront of modern biology. A major focus of the conference will be the influence of epigenetic (DNA, histone) methylation on gene expression and genome stability, and the contribution of dysregulated methylation to human diseases. New or highlighted in this meeting is an emphasis on epigenetic programming, environmental influences on the epigenome, therapeutic opportunities in epigenetics, and new scientific and technologic advances in the field in studying histone/DNA methylation. Other sessions will deal with the structure and function of DNA and protein methyltransferases/demethylases, and the post-translational methylation of non-histone proteins, which has emerged as an exciting new area of study, with central roles in signal transduction, the regulation of transcription and the DNA damage response. We intend to have diverse expertise of the meeting's attendees such that the participants have the opportunity to interact with one another to further advance our understanding of methylation and how methyltransferases and demethylases may be manipulated therapeutically to treat human diseases such as cancer. The Biological Methylation Conference is attended by a diverse group of junior and senior scientists from a wide range of academic and research institutions in the US and abroad. A major objective of the meeting is to promote interaction between junior scientists (postdoctoral fellows, graduate students, starting investigators) and more senior established investigators. Toward this end, we are including a session entitled "Meet the Experts" - an informal venue designed to permit young scientists an opportunity to meet leaders in the field to talk science and network. The conference format includes nine plenary sessions (36 invited and 18 selected from submitted abstracts), two "Recent Advances" minisymposia (consisting of 8 speakers selected from submitted abstracts), one Workshop (consisting of 4 speakers), and two poster sessions. Ample time will be provided for the 150 expected participants to socialize and to interact on an informal basis.

描述（由申请人提供）： 该提案寻求对2014年美国实验生物学学会联合会（FASEB）夏季研究会议“生物甲基化：染色质，表观遗传学和疾病的调节”的部分支持。这将是关于这一主题的第十一次两年期会议，将于2014年7月6日至12日在巴哈马拿骚喜来登赌场和度假村举行。“生物甲基化”会议在历史上采取了独特的方法，综合报道了S-腺苷甲硫氨酸依赖性甲基化的酶学，功能和识别及其对各种生物过程和疾病的影响。在过去的二十年里，这个会议已经发展成为一个特别关注与DNA和组蛋白甲基化有关的主题，以及这些表观遗传修饰在发育和疾病中的作用。表观遗传重编程领域的最新进展，涉及在发育和疾病期间重新设置DNA和组蛋白甲基化模式，以及全面评估DNA甲基化和组蛋白甲基化的基因组规模技术的演变，使该领域处于现代生物学的前沿。会议的一个主要焦点将是表观遗传（DNA，组蛋白）甲基化对基因表达和基因组稳定性的影响，以及甲基化失调对人类疾病的贡献。本次会议的新内容或重点是强调表观遗传编程，环境对表观基因组的影响，表观遗传学的治疗机会以及研究组蛋白/DNA甲基化领域的新科学和技术进展。其他会议将涉及DNA和蛋白质甲基转移酶/脱甲基酶的结构和功能，以及非组蛋白的翻译后甲基化，这已成为一个令人兴奋的新的研究领域，在信号转导，转录调节和DNA损伤反应中起着重要作用。我们打算让与会者拥有不同的专业知识，这样与会者就有机会相互交流，以进一步加深我们对甲基化的理解，以及如何在治疗上操纵甲基转移酶和去甲基化酶来治疗人类疾病，如癌症。生物甲基化会议由来自美国和国外广泛的学术和研究机构的初级和高级科学家组成的多元化团体参加。会议的一个主要目标是促进初级科学家（博士后研究员、研究生、新研究员）和更资深的既定研究员之间的互动。为此目的，我们将包括一个题为“会见专家”的会议-这是一个非正式的场所，旨在使年轻科学家有机会会见该领域的领导人，讨论科学和网络问题。会议形式包括九次全体会议（邀请36人，从提交的摘要中选出18人），两次“最新进展”小型讨论会（由从提交的摘要中选出的8名发言者组成），一次研讨会（由4名发言者组成）和两次海报会议。将为预计的150名与会者提供充足的时间进行社交和非正式互动。